FHIR IG analytics31,798 resources
By Version
By Realm
Start Prev Rows 2800 - 3000 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1147.198.json | Not Present On Admission or Documentation Insufficient to Determine | active | 2022-04 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.1.json | DEXA Dual Energy Xray Absorptiometry, Bone Density | active | 2016-07 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.11.json | Bladder Cancer Staging Ta for Urology Care | active | 2016-07 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.12.json | Bladder Cancer staging T1 for Urology Care | active | 2024-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.13.json | Bladder Cancer staging Tis for Urology Care | active | 2024-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.15.json | Carcinoma of urinary bladder, superficial | active | 2016-07 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.16.json | Injection Leuprolide Acetate | active | 2017-08 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.17.json | High grade bladder cancer Ta for Urology Care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.18.json | Immunocompromised state for Urology Care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.19.json | Systemic chemotherapy for urology care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.2.json | Bladder Cancer in Situ | active | 2016-07 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.20.json | Corticosteroids for patients receiving Urology Care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.21.json | Calcineurin inhibitors for patients receiving Urology Care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.23.json | Immunomodulators for patients undergoing Urology Care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.24.json | Monoclonal antibody for patient undergoing Urology Care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.28.json | Radiotherapy for patients undergoing Urology Care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.29.json | Plasmacytoid cell, morphologic abnormality for urology care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.3.json | Bladder Cancer in Situ | active | 2024-02 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.30.json | Sarcomatoid, morphologic abnormality for Urology Care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.31.json | Micropapillary, morphologic abnormality, for Urology Care | active | 2017-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.32.json | Immunosuppressive Drugs for Urology Care | active | 2024-02 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.38.json | DEXA Dual Energy Xray Absorptiometry, Bone Density for Urology Care | active | 2017-08 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.39.json | Mixed histology urothelial cell carcinoma for Urology Care | active | 2023-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.4.json | BCG Bacillus Calmette Guerin, Tice | active | 2016-07 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.40.json | Cystectomy for Urology Care | active | 2017-03 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.44.json | Unavailability of Bacillus Calmette Guerin for urology care | active | 2017-03 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.45.json | Bladder Cancer for Urology Care | active | 2017-03 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.48.json | Androgen deprivation therapy for Urology Care | active | 2021-02 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.5.json | BCG Bacillus Calmette Guerin, Connaught | active | 2016-07 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.52.json | BCG Bacillus Calmette Guerin for Urology Care | active | 2020-02 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.53.json | Cystectomy for Urology Care | active | 2018-04 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.54.json | Acute Tuberculosis for Urology Care | active | 2018-04 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.55.json | Cystectomy for Urology Care | active | 2022-03 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.56.json | Active Tuberculosis for Urology Care | active | 2018-04 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.57.json | Bladder Cancer Staging Tis for Urology Care | active | 2019-07 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.58.json | Bladder Cancer Staging Tis for Urology Care | active | 2019-07 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.59.json | Hospital Services for Urology | active | 2023-02 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.6.json | Peripheral DXA Scan | active | 2016-07 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.60.json | Chemotherapy Agents for Advanced Cancer | active | 2024-02 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.8.json | Tuberculosis Diagnosis Prior to Urology Care | active | 2016-07 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1151.9.json | Leukemia Diagnosis Prior to Urology Care | active | 2016-07 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.13.json | Preventative Clinical Encounters | active | 2025-03 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.14.json | Intensive Lifestyle Interventions | active | 2023-01 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.15.json | Intensive Lifestyle Interventions | active | 2023-01 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.16.json | Intensive Lifestyle Interventions | active | 2023-01 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.17.json | Intensive lifestyle interventions | active | 2023-01 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.21.json | Outpatient Clinical Encounters | active | 2025-03 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.22.json | Outpatient Clinical Encounters | active | 2025-03 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.23.json | Outpatient Clinical Encounters | active | 2025-03 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.24.json | Outpatient Clinical Encounters | active | 2025-03 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.25.json | Reason for No Intensive Lifestyle Intervention | active | 2023-01 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.27.json | Type 2 Diabetes Diagnoses | active | 2023-01 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.28.json | Type 2 Diabetes Diagnoses | active | 2023-01 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.29.json | Type 2 Diabetes Diagnoses | active | 2023-01 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.30.json | Prediabetes HbA1c Tests | active | 2023-01 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.31.json | Prediabetes HbA1c Tests | active | 2023-01 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.32.json | Prediabetes HbA1c Tests | active | 2023-01 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.33.json | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.34.json | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.35.json | Prediabetes Oral Glucose Tolerance Tests | active | 2023-01 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.36.json | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.37.json | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.38.json | Prediabetes Fasting plasma glucose or Plasma Glucose Tests | active | 2023-01 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.4.json | Glycemic Screening Tests | active | 2025-03 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.40.json | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.41.json | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.42.json | Sickle Cell Disease with Vaso Occlusive Episode | active | 2024-05 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.43.json | Analgesics for Acute Pain | active | 2025-02 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.49.json | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.5.json | Glycemic Screening Tests | active | 2023-01 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.52.json | Remote Physiologic Blood Pressure Monitoring | active | 2024-10 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.57.json | Aldosterone Receptor Blocker for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.58.json | Alpha Blocker for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.59.json | Angiotensin Converting Enzyme Inhibitor for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.6.json | Glycemic Screening Tests | active | 2023-01 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.60.json | Angiotensin II Receptor Blocker for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.61.json | Beta Blocker for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.62.json | Calcium Channel Blocker Dihydropyridine for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.63.json | Calcium Channel Blocker Non Dihydropyridine for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.64.json | Central Acting for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.65.json | Direct Renin Inhibitor for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.66.json | Loop Diuretic for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.67.json | Neuronal Blocking Agent for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.68.json | Potassium Sparing Diuretic for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.69.json | Thiazide Diuretic for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.7.json | Preventative Clinical Encounters | active | 2025-03 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.70.json | Vasodilator for Hypertension | active | 2024-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.73.json | Analgesics for Acute Pain (Non Parenteral Route) | active | 2025-02 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.74.json | Analgesics for Acute Pain (Parenteral Route) | active | 2025-02 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.75.json | Analgesics for Acute Pain Non Oral Enteral/Mucosal Routes | active | 2024-11 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.77.json | Antihypertensive Medication Classes | active | 2024-10 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.78.json | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.79.json | Medication Therapy Management Services for Essential Hypertension | active | 2024-10 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.8.json | Preventative Clinical Encounters | active | 2025-03 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.84.json | Renal Colic | active | 2025-04 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.85.json | Renal Colic | active | 2025-04 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.86.json | Renal Colic | active | 2025-04 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.88.json | Direct LDL Cholesterol | active | 2025-05 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.89.json | Calculated LDL Cholesterol | active | 2025-05 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1160.9.json | Preventative Clinical Encounters | active | 2025-03 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.50.json | Urinary retention | active | 2017-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.51.json | Urinary retention | active | 2017-06 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.52.json | Urinary retention | active | 2017-06 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.65.json | Morbid Obesity | active | 2018-04 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.66.json | Morbid Obesity | active | 2018-04 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.67.json | Morbid Obesity | active | 2018-04 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.68.json | BMI greater than 40 | active | 2019-02 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1164.69.json | Morbid Obesity | active | 2019-02 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.141.json | Contraceptive Patch SNOMED Devices | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.143.json | Live Birth Delivery CPT Procedures | active | 2024-09 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.144.json | Contraceptive Patch SNOMED Provision Procedures | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.145.json | Contraceptive Patch SNOMED Findings | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.146.json | Contraceptive Patch ICD10CM Provision Encounters | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.147.json | Contraceptive Patch ICD10CM Surveillance | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.148.json | Live Birth Delivery ICD10PCS Procedures | active | 2024-09 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.149.json | Contraceptive Patch HCPCS Devices | active | 2021-10 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.15.json | Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests | active | 2025-03 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.150.json | Contraceptive Patch LOINC | active | 2021-10 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.152.json | Live Birth Delivery Procedures SNOMED CT | active | 2024-09 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.153.json | Contraceptive Ring SNOMED Surveillance Procedures | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.154.json | Contraceptive Ring SNOMED Provision Procedures | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.155.json | Contraceptive Ring SNOMED Findings | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.156.json | Contraceptive Ring ICD10CM Provision Encounters | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.157.json | Contraceptive Ring ICD10CM Surveillance | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.159.json | Contraceptive Ring HCPCS Devices | active | 2022-01 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.160.json | Contraceptive Ring LOINC | active | 2021-10 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.161.json | Contraceptive Implant SNOMED Devices | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.162.json | Contraceptive Implant ICD10PCS Provision Procedures | active | 2021-10 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.163.json | Contraceptive Implant SNOMED Provision Procedures | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.164.json | Contraceptive Implant SNOMED Findings | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.170.json | Contraceptive Implant ICD10CM Provision Encounters | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.171.json | Contraceptive Implant ICD10CM Surveillance | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.173.json | Contraceptive Implant HCPCS Devices | active | 2021-10 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.174.json | Contraceptive Patch Devices | active | 2022-03 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.177.json | Live Birth Delivery Procedures | active | 2024-09 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.178.json | Contraceptive Ring Surveillance | active | 2021-10 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.180.json | Contraceptive Implant CPT Provision Procedures | active | 2021-10 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.181.json | Injectable Contraceptive SNOMED Surveillance Procedures | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.182.json | Injectable Contraceptive SNOMED Provision Procedures | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.183.json | Injectable Contraceptive SNOMED Findings | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.185.json | Injectable Contraceptive ICD10CM Provision Encounters | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.186.json | Injectable Contraceptive ICD10CM Surveillance | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.187.json | Injectable Contraceptive HCPCS Provision Procedures | active | 2021-10 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.188.json | Injectable Contraceptive LOINC | active | 2021-10 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.189.json | Oral Contraceptive Pill SNOMED Surveillance Procedures | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.190.json | Oral Contraceptive Pill SNOMED Provision Procedures | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.191.json | Oral Contraceptive Pill SNOMED Findings | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.193.json | Oral Contraceptive Pill ICD10CM Provision Encounters | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.194.json | Oral Contraceptive Pill ICD10CM Surveillance | active | 2021-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.195.json | Oral Contraceptive Pill HCPCS Provision Procedures | active | 2021-10 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.196.json | Oral Contraceptive Pill LOINC | active | 2021-10 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.197.json | Injectable Contraceptive Provision Procedures | active | 2022-03 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.198.json | Injectable Contraceptive Surveillance | active | 2021-10 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.199.json | Oral Contraceptive Pill Provision Procedures | active | 2022-03 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.200.json | Oral Contraceptive Pill Surveillance | active | 2021-10 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.201.json | Contraceptive Implant Devices | active | 2022-03 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.202.json | Contraceptive Implant Provision Procedures | active | 2022-03 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.203.json | Contraceptive Implant Surveillance | active | 2021-10 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.96.json | Infecund Not for Contraceptive Reasons SNOMED Findings | active | 2021-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.10.json | ASN Screening Declined | active | 2024-06 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.2.json | Intracranial or Intraspinal surgery | active | 2022-02 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.22.json | Emergency Department Observation | active | 2024-09 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.27.json | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.28.json | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.29.json | Bed Assigned | active | 2024-05 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.3.json | Malignant Intracranial Neoplasm Group | active | 2022-03 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.31.json | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.32.json | Healthcare Agent and Power of Attorney Documentation | active | 2024-09 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.33.json | Advance Directive Documentation | active | 2024-10 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.34.json | Advance Directive Documentation | active | 2024-11 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.35.json | Advance Directive Documentation | active | 2024-09 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.36.json | Portable Medical Order(s) Documentation | active | 2024-10 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.37.json | Portable Medical Order(s) Documentation | active | 2024-09 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.38.json | Advance Care Planning Discussion Documentation | active | 2024-11 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.4.json | Thrombolytic medications | active | 2021-10 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.40.json | Advance Care Planning Documentation | active | 2024-09 | us | cpt | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.41.json | Advance Care Planning Documentation | active | 2024-09 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.42.json | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.43.json | Advance Directive Documentation | active | 2024-10 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.45.json | Advance Care Planning Documentation | active | 2024-11 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.46.json | Advance Care Planning Documentation | active | 2024-10 | us | icd | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.47.json | Portable Medical Order(s) Documentation | active | 2024-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.48.json | Portable Medical Order(s) Documentation | active | 2024-10 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.49.json | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.5.json | Allergy to thrombolytics | active | 2025-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.50.json | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.51.json | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.52.json | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.53.json | Intervention for Positive Housing Instability Screen | active | 2024-11 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.54.json | Intervention for Positive Housing Instability Screen | active | 2024-11 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.55.json | Intervention for Positive Homelessness Screen | active | 2024-11 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.56.json | Intervention for Positive Homelessness Screen | active | 2024-11 | us | vsac | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.57.json | Non Invasive Oxygen Therapy Device Codes | active | 2025-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.58.json | Goals, preferences, and priorities for medical treatment | active | 2025-04 | us | loinc | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.6.json | Thrombolytics Adverse Event | active | 2025-02 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.7.json | Intraspinal surgery | active | 2024-02 | us | cms | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1176.58.json | Food Insecurity Screening Positive | active | 2023-10 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.1.json | Ezetimibe Therapy | active | 2023-02 | us | rx | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.100.json | Allergy or Intolerance to ACE Medication | active | 2024-11 | us | sct | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.101.json | Allergy or Intolerance to ARB Medication | active | 2024-11 | us | sct |